Study finds no link between oral bisphosphonates and cancer risk

08/10/2010 | Bloomberg Businessweek

An analysis of medical data from more than 80,000 U.K. patients found that using bisphosphonates, a class of osteoporosis drugs, doesn't increase the risk of esophageal or gastric cancer. Researchers found no difference in combined incidence of the cancers between bisphosphonate users and nonusers.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA